293 results
Page 6 of 15
8-K
EX-99.1
1sqw 2cuu235
27 Jan 20
Other Events
10:59am
8-K
EX-99.1
v5cea7q
21 Jan 20
Trovagene to Present New Clinical Data for Onvansertib in Metastatic KRAS-Mutated Colorectal Cancer at ASCO 2020 Gastrointestinal Cancers Symposium
10:09am
8-K
EX-99.1
93w9n2uti mkvhd
9 Dec 19
Efficacy, Durability of Response and Safety of Onvansertib Demonstrated in Completed Phase 1b Trial in AML Patients Presented in Oral Session at ASH
2:49pm
8-K
EX-99.1
29tho7g 26lpjjo
4 Dec 19
Other Events
12:15pm
8-K
EX-99.1
xt1yly4oor1f ci00
14 Nov 19
Other Events
9:07am
8-K
EX-99.1
n1l xcl64qqot2q
7 Nov 19
Trovagene Announces Third Quarter 2019 Results and Highlights
4:21pm
8-K
EX-99.1
88csy6u ms2w0
6 Nov 19
Trovagene Announces Data from Acute Myeloid Leukemia (AML) Phase 1b/2 Trial of Onvansertib Chosen for Oral Presentation at ASH 2019 Annual Meeting
12:41pm
D
icnxndo
30 Oct 19
$5M in equity / options / securities to be acquired, sold $5M, 2 investors
4:51pm
8-K
EX-99.1
8l97a8f7
28 Oct 19
Trovagene Announces $5.0 Million Private Placement PricedAt-the-Market
4:52pm
8-K
EX-10.1
cufoys z01zux34nvz
28 Oct 19
Trovagene Announces $5.0 Million Private Placement PricedAt-the-Market
4:52pm
8-K
EX-99.1
hlltn hl39x43p6l
22 Oct 19
Trovagene Announces Positive Response to Treatment in Phase 1b/2 Trial of Onvansertib in Patients with KRAS-Mutated Metastatic Colorectal Cancer
10:30am
8-K
EX-9.01
y1xyl
2 Oct 19
Other Events
10:33am
8-K
EX-9.01
wxbw0psh
1 Oct 19
Other Events
10:50am
8-K
EX-9.01
c3jln8
30 Sep 19
Other Events
12:46pm
8-K
EX-99.1
yz7bvyz7ys1qui2zig
19 Sep 19
Other Events
10:06am
8-K
EX-99.1
pal790v8wg5hp2l9e1
26 Aug 19
Other Events
1:50pm
8-K
EX-10.1
0wol151fwu4d
21 Aug 19
Entry into a Material Definitive Agreement
8:25am
8-K
EX-99.1
nuxf1av
8 Aug 19
Trovagene Announces Second Quarter 2019 Results and Highlights
4:53pm
8-K
EX-99.1
g89q7xk6554yldvxhapz
22 Jul 19
ESMO Accepts Trovagene AML Clinical Trial Abstract for Oral Presentation
11:55am
8-K
EX-99.1
m1wpej5sodiwhdng0r1
15 Jul 19
Regulation FD Disclosure
12:03pm